Management of Pulmonary Nodules Detected on CT

Initial Risk Stratification

The American College of Chest Physicians recommends estimating the probability of malignancy using validated prediction models, such as the Mayo Clinic or Brock model, and patient risk factors for solid nodules ≥8 mm in diameter, then proceeding with CT surveillance for low-risk nodules (<10% malignancy probability), PET-CT for intermediate-risk nodules (10-70%), and surgical resection or biopsy for high-risk nodules (>65-70%) 1, 2, 3
For solid nodules <8 mm, the management pathway depends on nodule size and risk factors, with specific follow-up recommendations for nodules ≤4 mm, >4-6 mm, and >6-8 mm 1, 4

For low probability (<10%), CT surveillance is recommended, with initial follow-up at 3-6 months and subsequent imaging at 9-12 months and 24 months 1, 3
For intermediate probability (10-70%), PET-CT is recommended for further risk stratification, with a sensitivity of 97% and specificity of 78% for nodules ≥1 cm 2, 3
For high probability (>65-70%), surgical resection is recommended, with video-assisted thoracoscopic surgery (VATS) for diagnostic wedge resection as the preferred approach 1, 4

For pure ground-glass nodules, no follow-up is required for nodules ≤5 mm, while annual CT surveillance is recommended for nodules >5 mm 4, 3
For part-solid nodules, management is based on the solid component size, with CT surveillance and PET-CT recommended for nodules with a solid component >8 mm 3, 4

Benign indicators, such as diffuse, central, laminated, or popcorn calcification, macroscopic fat, and typical perifissural nodules, do not require follow-up 2, 3
Malignant indicators, such as spiculation, pleural indentation, upper lobe location, and volume doubling time <400 days, increase suspicion for malignancy 1, 2

All surveillance CT imaging must include thin sections ≤1.5 mm, coronal and sagittal reconstructions, and low-dose, non-contrast technique for solid nodules ≤8 mm 3, 5
Volumetric analysis is recommended when available, and prior imaging should always be obtained to assess stability 1, 5

Skipping surveillance based solely on negative PET-CT for nodules 8-10 mm, as PET sensitivity is limited below 1 cm 3
Assuming multiple bilateral nodules are all metastatic, as >85% of additional nodules may be benign 6
Approximately 20% of lung cancers decrease in size at some point during observation, so size reduction does not exclude malignancy 1
Nondiagnostic biopsy results do not exclude malignancy and may require repeat sampling or surgical resection 3